The Peter Attia Drive

Podbit · The Peter Attia Drive

#392 - Genetic testing: when it's valuable, how to choose the right test, and what to do with the results

Explore episode May 18, 2026

Where this was said

Genetic testing for cancer risk: inherited syndromes, clinical utility, and the limits of consumer testing

At 25:18 · chapter starts 24:00

Cancer is where the conversation becomes most nuanced, because cancer is fundamentally a genetic disease — but most of it is not inherited. Approximately 95% of cancers arise from somatic mutations that accumulate over a lifetime and will not appear on any germline genetic test. The 5% that are inherited, however, matter enormously, because they tend to involve highly penetrant mutations that carry substantial lifetime risk and that change clinical management in meaningful ways. BRCA1, BRCA2, and Lynch syndrome are the clearest examples: women with BRCA mutations face lifetime risks of breast and ovarian cancer high enough that enhanced screening, chemoprevention, and even prophylactic surgery can be appropriate. Lynch syndrome mutations dramatically increase colorectal cancer risk, and knowing one's status saves lives by intensifying screening protocols. Peter then addresses a critical technical point: the original 23andMe test checked only 3 pathogenic BRCA variants out of thousands. A negative consumer result is therefore not a negative clinical result — it simply means the person does not carry one of three well-studied mutations. For any meaningful cancer genetic risk assessment, clinical-grade panel testing is required.

Health & Fitness
APOE4 and Alzheimer's: High Risk, Limited Playbook

#392 - Genetic testing: when it's valuable, how to choose t… · May 18, 2026 Health & Fitness

Two copies of APOE4 can raise Alzheimer's risk up to 15-fold, yet it is still not destiny — roughly half of Alzheimer's patients carry no APOE4 at all. Knowing your status can sharpen risk factor management and inform long-term planning, but it doesn't yet map onto established preventive interventions.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.